Cécile Gouttefangeas

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Topics

Prostate Cancer

Immune Response

Top Venues

Cancer immunology, immunotherapy : CII

Seminars in immunopathology

This page only lists publications with an associated author ORCID identifier.

Publications

Juliane Schuhmacher, Leon Kleemann, Jennifer Rebecca Richardson, Elisa Rusch, Hans-Georg Rammensee, Cécile Gouttefangeas
Simultaneous Identification of Functional Antigen-Specific CD8 + and CD4 + Cells after In Vitro Expansion Using Elongated Peptides. Cells 11 (21) (2022)
Ana Maia, Anna Schöllhorn, Juliane Schuhmacher, Cécile Gouttefangeas
CAF-immune cell crosstalk and its impact in immunotherapy. Seminars in immunopathology (2022)
Nicola Herold, Anna Schöllhorn, Adrian Feile, Andrea Gaißler, Anne Mohrholz, Graham P Pawelec, Markus W Löffler, Stoyan Dimitrov, Cécile Gouttefangeas, Kilian Wistuba-Hamprecht
Integrin activation enables rapid detection of functional Vδ1 + and Vδ2 + γδ T cells. European journal of immunology 52 (5) (2022)
Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Sarah Walz, Annika Nelde, Sebastian P Haen, Michael Reth, Jianying Yang, Ghazaleh Tabatabai, Hans Bösmüller, Helen Hoffmann, Michael Schindler, Oliver Planz, Karl-Heinz Wiesmüller, Markus W Löffler
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines 9 (5) (2021)
Juliane Schuhmacher, Sonja Heidu, Torben Balchen, Jennifer Rebecca Richardson, Camilla Schmeltz, Jesper Sonne, Jonas Schweiker, Hans-Georg Rammensee, Per Thor Straten, Martin Andreas Røder, Klaus Brasso, Cécile Gouttefangeas
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial. Journal for immunotherapy of cancer 8 (2) (2021)
Natalia Teresa Jarzebska, Julia Frei, Severin Lauchli, Lars E French, Emmanuella Guenova, Cécile Gouttefangeas, Emmanuella Guenova, Mark Mellett, Steve Pascolo
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring. Viruses 13 (7) (2021)
Jennifer Rebecca Richardson, Anna Schöllhorn, Cécile Gouttefangeas, Juliane Schuhmacher
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy. Cancers 13 (4) (2021)
Cécile Gouttefangeas, Juliane Schuhmacher, Stoyan Dimitrov
Adhering to adhesion: assessing integrin conformation to monitor T cells. Cancer immunology, immunotherapy : CII 68 (11) (2019)
Cécile Gouttefangeas, Hans-Georg Rammensee
Personalized cancer vaccines: adjuvants are important, too. Cancer immunology, immunotherapy : CII 67 (12) (2018)